In addition, monocytes that downregulate CD62L (Mo F+L- monocytes expressing SiglecF and lower levels of CD62L) also displayed similar statistical trends, but these were for distinguishing 4T1-bearing mice from both CT26-bearing and no-tumor control mice (Figure 6A). This evidence concerns the gene SELL and neoplasm.